Search
Carlsmed Ord Shs
CARLAdd to Watchlist
14.910USD
+0.380+2.62%
Close 10-26 16:00（ET）
407.04MMarket Cap
LossP/E TTM
After-hours 17:17 (ET)15.180USD+0.280+1.88%
After-hours 17:17 (ET)Carlsmed Ord Shs (CARL) Stock Price Target & Forecast
Analyst Rating
Based on 5 analysts
Buy
2 Strong Buy
3 Buy
0 Hold
0 Sell
0 Strong Sell
Target Price
19.200USD+43.18%
CARL Analyst Recommendation Trends
In the current month, CARL has received 3 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. CARL average Analyst price target in the last month is 19.200.
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2
2
2
2
2
2
2
2
3
3
3
3
3
3
3
3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5
5
5
5
5
5
5
5
CARL Analyst Rating for Peer Comparison
Updated: Oct 20, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Medtronic PLC
MDT
9
11
11
0
0
31
Dexcom Inc
DXCM
13
13
4
0
0
30
Stryker Corp
SYK
10
14
5
0
0
29
Abbott Laboratories
ABT
11
14
4
0
0
29
Medline Ord Shs Class A
MDLN
10
12
6
0
0
28
Zimmer Biomet Holdings Inc
ZBH
2
6
20
0
0
28
Guardant Health Inc
GH
12
13
2
0
0
27
Insulet Corp
PODD
7
7
12
0
0
26
Tandem Diabetes Care Inc
TNDM
5
8
11
0
0
24
Repligen Corp
RGEN
5
13
3
0
0
21
Financial Forecasting
Based on analysts' estimates, CARL EPS is projected to reach -0.401 in FY2026Q3, following reported EPS of -0.387 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-0.43
-0.39
-0.41
-0.40
-0.38
Actual
-0.32
-0.32
-0.39
--
--
Surprise
+24.37%
+17.34%
+5.26%
--
--
FAQs
What is Carlsmed Ord Shs's expected revenue for the next quarter?
Carlsmed Ord Shs's expected revenue is 19.15M.
What is Carlsmed Ord Shs's price target?
Analysts forecast that Carlsmed Ord Shs's price target is USD 19.20, with the highest forecast at USD 23.00 and the lowest forecast at USD 17.00.
How have Carlsmed Ord ShsCARL's recent earnings per share performed?
The market expectation was USD -0.39, while Carlsmed Ord ShsCARL's earnings per share (EPS) for the previous quarter was USD -0.32. EPS for the next quarter is expected at USD -0.40.
What is the analyst rating for Carlsmed Ord Shs?
Based on the ratings of Carlsmed Ord Shs's stock from 5 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.